Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (BBNX)

Historical Holders from Q1 2025 to Q4 2025

Symbol
BBNX on Nasdaq
Type / Class
Equity / Common Stock, $0.0001 par value per share (the "Shares")
Shares outstanding
43,574,949
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
48,310,134
Holdings value
$959,915,542
% of all portfolios
0%
Number of holders
127
Number of buys
84
Number of sells
37
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (BBNX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
EVENTIDE ASSET MANAGEMENT, LLC 11% $52,456,043 4,857,041 Eventide Asset Management, LLC 31 Jan 2025
Zone Healthcare Holdings, LLC 9.9% +25% $85,717,590 +$17,618,729 4,313,920 +26% Dapice Joshua J. 30 Sep 2025
Farallon Capital Partners, L.P. 9.7% $57,005,155 4,203,920 Dapice Joshua J. 30 Jun 2025
Wellington Hadley Harbor Aggregator IV, L.P. 9% +31% $42,137,269 +$10,800,000 3,901,599 +34% Wellington Hadley Harbor Aggregator IV, L.P. 31 Mar 2025
WELLINGTON MANAGEMENT GROUP LLP 9% $42,137,269 3,901,599 Wellington Management Group LLP 31 Mar 2025
Soleus BB SPV, LLC 8.8% $40,989,683 3,795,341 Soleus Capital Management, L.P. 31 Mar 2025
MORGAN STANLEY 8.6% +26% $74,305,196 +$16,109,185 3,739,567 +28% Morgan Stanley 30 Sep 2025
Sands Capital Life Sciences Pulse Fund II, L.P. 8.2% +13% $48,410,732 +$5,636,946 3,570,113 +13% Sands Capital Life Sciences Pulse Fund II. L.P. 30 Jun 2025
RTW INVESTMENTS, LP 7.6% $35,638,585 3,299,869 RTW Investments, LP 31 Mar 2025
BlackRock, Inc. 6.4% $55,215,708 2,778,764 BlackRock, Inc. 30 Sep 2025
VANGUARD GROUP INC 5.1% $44,035,596 2,216,185 The Vanguard Group 30 Sep 2025
PERCEPTIVE ADVISORS LLC 3.7% $21,609,324 1,593,608 Perceptive Advisors LLC 31 Mar 2025
MILLENNIUM MANAGEMENT LLC 1.8% -70% $15,835,993 -$29,602,207 796,964 -65% Millennium Management LLC 30 Sep 2025
As of 30 Sep 2025 Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (BBNX) has 127 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 48,310,134 shares of the company stock as of 30 Sep 2025.

Institutional Holders of Beta Bionics, Inc. - Common Stock, $0.0001 par value per share (the "Shares") (BBNX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 779 $23,736 +$4,723 $30.47 1
2025 Q3 48,310,134 $959,915,542 +$85,339,869 $19.87 127
2025 Q2 44,848,348 $652,883,600 +$53,846,940 $14.56 114
2025 Q1 41,702,710 $507,967,865 +$504,374,335 $12.24 102